Trial Profile
A Study to Evaluate the Effect of Sitagliptin on Circulating Cytokine Levels in Newly Diagnosed Type 2 Diabetes Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 May 2016
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 26 May 2016 New trial record